Tag Archives: NTRA

Top Dividend Stocks To Invest In Right Now

Each day, Benzinga takes a look back at a notable market-related moment that occurred on this date.

What Happened?

On this day 32 years ago, Kidder, Peabody & Co. paid a $25.3-million fine for insider trading.

Where The Market Was

The Dow closed at 2,337.08. The S&P 500 traded at around 295.09. Today, the Dow is trading at 24,635.21 and the S&P 500 is trading at 2,734.62.

What Else Was Going On In The World?

In 1987, the popular sitcom “Full House” debuted on ABC. U.S. President Ronald Reagan famously urged Soviet Union leader Mikhail Gorbachev to “tear down this wall” during a speech in West Berlin. A dozen eggs cost 65 cents.

Insider Trading Crackdown

Kidder, Peabody & Co. was a securities firm that was founded in Massachusetts in 1865. General Electric Company (NYSE: GE) acquired Kidder in 1986, and almost immediately the company was slammed by several insider trading scandals.

Former executive Martin Siegel admitted to making trades based on inside information and implicated chief arbitrageur Richard Wigton of doing the same.

United States Attorney for the Southern District of New York Rudy Giuliani threatened to indict GE, prompting the company to conduct its own internal investigation. As a result of the investigation, GE fired three senior Kidder executives.

Top Dividend Stocks To Invest In Right Now: Guaranty Bancorp(GBNK)

Guaranty Bancorp (the “Company”) is a bank holding company registered under the Bank Holding Company Act of 1956, as amended (the “BHC Act”) and headquartered in Colorado. The Company’s principal business is to serve as a holding company for our bank subsidiary, Guaranty Bank and Trust Company referred to as “Guaranty Bank” or “Bank”.

References to the “Company”, “us”, “we” and “our” refer to Guaranty Bancorp on a consolidated basis. References to “Guaranty Bancorp” or to the “holding company” refer to the parent company on a stand-alone basis.

At December 31, 2015, we had total assets of $2.4 billion, net loans of $1.8 billion, deposits of $1.8 billion and stockholders’ equity of $221.6 million, and we operated 26 branches and two investment management firms in Colorado through our bank subsidiary, Guaranty Bank.   Advisors’ Opinion:

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Guaranty Bancorp (GBNK)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    Guaranty Bancorp (NASDAQ:GBNK) and County Bancorp (NASDAQ:ICBK) are both small-cap finance companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, earnings, valuation, analyst recommendations, dividends, risk and institutional ownership.

  • [By Ethan Ryder]

    Guaranty Bancorp (NASDAQ:GBNK) has earned a consensus recommendation of “Hold” from the six brokerages that are presently covering the company, MarketBeat.com reports. One research analyst has rated the stock with a sell rating, three have assigned a hold rating and two have given a buy rating to the company. The average 1-year target price among brokerages that have covered the stock in the last year is $34.63.

Top Dividend Stocks To Invest In Right Now: Natera, Inc.(NTRA)

Natera, Inc., a diagnostics company, provides preconception and prenatal genetic testing services. It primarily offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus typically with a blood draw from the mother; Horizon carrier screening to determine carrier status for various genetic diseases that could be passed on to the carriers children; and Spectrum pre-implantation genetic screening and Spectrum pre-implantation genetic diagnosis to analyze chromosomal anomalies or inherited genetic conditions during an in vitro fertilization cycle. The company also provides products of conception testing under the Anora brand to analyze fetal chromosomes to understand the cause of miscarriage; non-invasive paternity testing products to determine paternity by analyzing the fragments of fetal deoxyribonucleic acid in a pregnant mother’s blood and a blood sample from the alleged father. In addition, it offers Constellation, a cloud-based software product that allows laboratory customers to gain access through the cloud to the companys algorithms and bioinformatics in order to validate and launch tests. The company offers products through its direct sales force, as well as through a network of approximately 70 laboratory and distribution partners in the United States and internationally. The company was formerly known as Gene Security Network, Inc. and changed its name to Natera, Inc. in 2012. Natera, Inc. was founded in 2003 and is headquartered in San Carlos, California.

Advisors’ Opinion:

  • [By Maxx Chatsko]

    Shares of Natera (NASDAQ:NTRA) jumped nearly 25% today after the company announced fourth-quarter and full-year 2018 operating results. The business delivered impressive growth last year — as did its genetic testing peers — and expects that momentum to carry into 2019. That’s partly due to a potentially lucrative partnership with China’s genomics powerhouse, BGI, which was announced the day before. The genetic testing player will receive a net up-front payment of $44 million plus royalties on products and services provided in China.

  • [By Motley Fool Transcribers]

    Natera Inc (NASDAQ:NTRA)Q42018 Earnings Conference CallMarch 12, 2019, 4:30 p.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Daniel Sparks]

    Today’s after-hours headlines include food and beverage giant Kraft Heinz (NASDAQ:KHC) and healthcare diagnostics and research company Natera (NASDAQ:NTRA).

Top Dividend Stocks To Invest In Right Now: Match Group, Inc.(MTCH)

Match Group, Inc. provides dating products. It operates a portfolio of approximately 45 brands, including Match, OkCupid, Tinder, PlentyOfFish, Meetic, Twoo, OurTime, and FriendScout24. The company offers its dating products through its Websites and applications in 38 languages approximately in 190 countries. It also provides various test preparation, academic tutoring, and college counseling services. The company was incorporated in 2009 and is headquartered in Dallas, Texas. Match Group, Inc. is a subsidiary of IAC/InterActiveCorp.

Advisors’ Opinion:

  • [By Motley Fool Staff]

    For this episode, it’s time to check in on not one but two such samplers. First, it’s been one year since he offered up “Five Stocks I Own That You Should Too.” Those were Activision Blizzard(NASDAQ:ATVI), Alphabet(NASDAQ:GOOGL) (NASDAQ:GOOG),Intuitive Surgical(NASDAQ:ISRG), Match Group(NASDAQ:MTCH), and Zillow(NASDAQ:Z) (NASDAQ:ZG), and he’ll review their progress with senior analystJim Mueller.

  • [By Jeremy Bowman]

    Match Group(NASDAQ:MTCH), the parent of online dating brands including Tinder, OkCupid, Hinge, and its namesake, has been a breakout winner on the market since its 2015 IPO, with the stock nearly quadrupling since then.

  • [By Logan Wallace]

    Eventbrite (NYSE:EB) and Match Group (NASDAQ:MTCH) are both computer and technology companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, dividends, institutional ownership, valuation, earnings, risk and analyst recommendations.

Top Low Price Stocks To Buy Right Now

Protect American jobs by getting tough on China.

That’s the underlying idea behind President-elect Donald Trump’s threat of a 45% tariff against China as a ploy to bring jobs back to America.

Before pursuing that strategy, however, Trump might want to check out what happened when his predecessor tried that.

President Obama slapped a stiff 35% tariff on Chinese tires in 2009 after American companies complained about unfair competition. They said China was flooding America with tires at low prices making it tough for U.S. companies to compete. The tire tariff gradually waned, and finally ended in 2012.

The tariff saved 1,200 U.S. tire jobs, which had been in sharp decline. And U.S. tire production rose after a major decline.

“Over a thousand Americans are working today because we stopped a surge in Chinese tires,” Obama said in his 2012 State of the Union address.

But a study from the Peterson Institute of International Economics found that the tariffs cost Americans in many other ways.

Top Low Price Stocks To Buy Right Now: Patterson Companies, Inc.(PDCO)

Advisors’ Opinion:

  • [By Shane Hupp]

    American International Group Inc. grew its holdings in shares of Patterson Companies (NASDAQ:PDCO) by 320.9% in the 1st quarter, according to its most recent disclosure with the SEC. The fund owned 182,605 shares of the company’s stock after purchasing an additional 139,218 shares during the period. American International Group Inc. owned approximately 0.19% of Patterson Companies worth $4,059,000 as of its most recent SEC filing.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Patterson Companies (PDCO)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    Patterson Companies (NASDAQ:PDCO) had its price objective decreased by Morgan Stanley from $21.00 to $19.00 in a report released on Friday. Morgan Stanley currently has an underweight rating on the stock.

  • [By Joseph Griffin]

    Patterson Companies, Inc. (NASDAQ:PDCO) announced a quarterly dividend on Wednesday, September 19th, RTT News reports. Shareholders of record on Friday, October 12th will be given a dividend of 0.26 per share on Friday, October 26th. This represents a $1.04 dividend on an annualized basis and a yield of 4.40%. The ex-dividend date is Thursday, October 11th.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Patterson Companies (PDCO)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top Low Price Stocks To Buy Right Now: Balchem Corporation(BCPC)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Balchem (NASDAQ: BCPC) is one of 25 public companies in the “Chemicals & allied products” industry, but how does it contrast to its rivals? We will compare Balchem to similar businesses based on the strength of its analyst recommendations, earnings, valuation, dividends, profitability, institutional ownership and risk.

  • [By Max Byerly]

    Carillon Tower Advisers Inc. boosted its stake in Balchem Co. (NASDAQ:BCPC) by 656.3% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 55,180 shares of the basic materials company’s stock after purchasing an additional 47,884 shares during the period. Carillon Tower Advisers Inc. owned about 0.17% of Balchem worth $4,510,000 at the end of the most recent reporting period.

  • [By Logan Wallace]

    JPMorgan Chase & Co. boosted its position in shares of Balchem Co. (NASDAQ:BCPC) by 20.6% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 73,196 shares of the basic materials company’s stock after buying an additional 12,487 shares during the period. JPMorgan Chase & Co.’s holdings in Balchem were worth $5,985,000 at the end of the most recent quarter.

  • [By Stephan Byrd]

    Balchem Co. (NASDAQ:BCPC) – Equities research analysts at Seaport Global Securities lifted their Q2 2019 EPS estimates for shares of Balchem in a report issued on Thursday, February 28th. Seaport Global Securities analyst B. Hundley now forecasts that the basic materials company will post earnings per share of $0.81 for the quarter, up from their prior forecast of $0.80. Seaport Global Securities currently has a “Neutral” rating on the stock. Seaport Global Securities also issued estimates for Balchem’s Q3 2019 earnings at $0.78 EPS, Q4 2019 earnings at $0.83 EPS, FY2019 earnings at $3.15 EPS and FY2020 earnings at $3.30 EPS.

  • [By Travis Hoium]

    Balchem’s (NASDAQ:BCPC) fourth-quarter 2018 results, reported this week, showed continued solid revenue and earnings growth. Notably, the specialty-ingredients supplier achieved growth this year without the benefit of large acquisitions, which have helped results in the past. 

Top Low Price Stocks To Buy Right Now: Monroe Capital Corporation(MRCC)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Monroe Capital (NASDAQ:MRCC) had its price target reduced by National Securities from $17.00 to $16.00 in a research note issued to investors on Monday. National Securities currently has a buy rating on the financial services provider’s stock.

  • [By Logan Wallace]

    PJT Partners (NASDAQ: MRCC) and Monroe Capital (NASDAQ:MRCC) are both small-cap finance companies, but which is the better business? We will compare the two companies based on the strength of their valuation, risk, earnings, dividends, institutional ownership, profitability and analyst recommendations.

  • [By Ethan Ryder]

    Monroe Capital (NASDAQ:MRCC) was downgraded by research analysts at BidaskClub from a “strong-buy” rating to a “buy” rating in a note issued to investors on Friday.

  • [By Motley Fool Transcribers]

    Monroe Capital Corp  (NASDAQ:MRCC)Q4 2018 Earnings Conference CallMarch 06, 2019, 11:00 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

Top Low Price Stocks To Buy Right Now: Natera, Inc.(NTRA)

Advisors’ Opinion:

  • [By Max Byerly]

    Shares of Natera Inc (NASDAQ:NTRA) traded up 1% during mid-day trading on Monday after Morgan Stanley raised their price target on the stock from $21.00 to $41.00. Morgan Stanley currently has an overweight rating on the stock. Natera traded as high as $24.34 and last traded at $24.17. 12,757 shares were traded during trading, a decline of 99% from the average session volume of 958,145 shares. The stock had previously closed at $23.94.

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Natera (NTRA)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Daniel Sparks]

    Today’s after-hours headlines include food and beverage giant Kraft Heinz (NASDAQ:KHC) and healthcare diagnostics and research company Natera (NASDAQ:NTRA).

  • [By Logan Wallace]

    Natera (NASDAQ:NTRA) was downgraded by investment analysts at ValuEngine from a “buy” rating to a “hold” rating in a report issued on Monday.

  • [By Max Byerly]

    Natera Inc (NASDAQ:NTRA) shares traded down 10.7% during mid-day trading on Thursday after an insider sold shares in the company. The company traded as low as $21.99 and last traded at $22.14. 1,094,600 shares changed hands during mid-day trading, an increase of 173% from the average session volume of 400,551 shares. The stock had previously closed at $24.78.

Top 5 Value Stocks To Watch For 2018

Shares of iRhythm (NASDAQ:IRTC) reached a new 52-week high and low during mid-day trading on Thursday . The company traded as low as $69.99 and last traded at $68.10, with a volume of 7781 shares changing hands. The stock had previously closed at $69.16.

IRTC has been the topic of a number of recent research reports. Canaccord Genuity reiterated a “buy” rating and issued a $80.00 price objective (up from $68.00) on shares of iRhythm in a report on Monday, March 12th. BidaskClub upgraded shares of iRhythm from a “hold” rating to a “buy” rating in a report on Thursday, February 22nd. ValuEngine upgraded shares of iRhythm from a “hold” rating to a “buy” rating in a report on Wednesday. Zacks Investment Research upgraded shares of iRhythm from a “sell” rating to a “hold” rating in a report on Tuesday. Finally, Northland Securities restated a “hold” rating and set a $60.00 target price on shares of iRhythm in a report on Monday, April 16th. Four investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. The company presently has an average rating of “Buy” and a consensus price target of $69.29.

Top 5 Value Stocks To Watch For 2018: Liquor Stores N.A. Ltd. (LQSIF)

Advisors’ Opinion:

  • [By ]

    British Columbia and Alberta have chosen a different strategy where retail sales will be allowed through both public and private stores, similar to its current setup for liquor retail in the provinces. Retailers will have to get their supply of cannabis from the government’s wholesale distribution system, similar to how it works for alcohol now. The government will control online cannabis sales exclusively Our take: British Columbia also announced that physical retailing of cannabis and liquor will have to be separate, meaning stores cannot sell both products. This rule has an impact on existing liquor retailers aiming to convert some of their stores to sell cannabis. Aurora invested in Liquor Stores (renamed to Alcanna (OTCPK:LQSIF)) which has been struggling for years in the liquor business. Other pharmacy chains will also participate in the RFP as we have seen in Loblaw’s recent win in Newfoundland and Labrador. We think for many cannabis companies the path to winning those retail licenses will be a challenging one with the competition from multiple sources. The licenses will be hotly contested given that B.C. is the largest market to allow private retailing, leaving us cautious on those companies betting big on winning those contracts. The likely outcome is that a large number of companies will each win fewer contracts.

  • [By ]

    It also holds just under 20 percent share of Liquor Stores N.A. (OTCPK:LQSIF) and over 17 percent of Radient Technologies Inc. (OTC:RDDTF). Aurora has other holdings as well.

Top 5 Value Stocks To Watch For 2018: CYREN Ltd.(CYRN)

Advisors’ Opinion:

  • [By Lisa Levin] Companies Reporting Before The Bell
    Advance Auto Parts, Inc. (NYSE: AAP) is projected to report quarterly earnings at $1.97 per share on revenue of $2.91 billion.
    Kohl's Corporation (NYSE: KSS) is expected to report quarterly earnings at $0.5 per share on revenue of $3.95 billion.
    The TJX Companies, Inc. (NYSE: TJX) is projected to report quarterly earnings at $1.02 per share on revenue of $8.47 billion.
    AutoZone, Inc. (NYSE: AZO) is estimated to report quarterly earnings at $13.01 per share on revenue of $2.72 billion.
    Dycom Industries, Inc. (NYSE: DY) is projected to report quarterly earnings at $0.7 per share on revenue of $734.86 million.
    Eaton Vance Corp. (NYSE: EV) is estimated to report quarterly earnings at $0.79 per share on revenue of $425.42 million.
    Photronics, Inc. (NASDAQ: PLAB) is expected to report quarterly earnings at $0.07 per share on revenue of $124.17 million.
    Cracker Barrel Old Country Store, Inc. (NASDAQ: CBRL) is estimated to report quarterly earnings at $1.93 per share on revenue of $715.15 million.
    Radcom Ltd. (NASDAQ: RDCM) is expected to post quarterly earnings at $1.96 per share on revenue of $718.59 million.
    Clear Channel Outdoor Holdings, Inc. (NYSE: CCO) is projected to report quarterly earnings at $0.04 per share on revenue of $718.96 million.
    CYREN Ltd. (NASDAQ: CYRN) is estimated to report quarterly loss at $0.08 per share on revenue of $7.72 million.
    Ferroglobe PLC (NYSE: GSM) is projected to report quarterly earnings at $0.16 per share on revenue of $559.15 million.
    Dr. Reddy's Laboratories Limited (NYSE: RDY) is estimated to report earnings for its fourth quarter.
    BioLineRx Ltd. (NASDAQ: BLRX) is expected to report quarterly loss at $0.07 per share.
    Toll Brothers, Inc. (NYSE: TOL) is estimated to post quarterly earnings at $0.76 per share on revenue of $1.58 billion.

     

  • [By Lisa Levin] Gainers
    Regional Health Properties, Inc. (NYSE: RHE) shares surged 56 percent to $0.3980.
    Precipio, Inc. (NASDAQ: PRPO) shares jumped 34 percent to $0.5632 after the nano-cap specialty diagnostics company said it saw an acceleration of sales in its Pathology services in April. The company now expects to see a sequential double digit quarterly sales growth.
    SenesTech, Inc. (NASDAQ: SNES) rose 16 percent to $1.45 after trading higher at one point Monday by nearly 300 percent. The nano-cap developer of pest control said the California state government approved the company's ContraPest for user in the state.
    America's Car-Mart, Inc. (NASDAQ: CRMT) gained 13.3 percent to $61.975 after reporting upbeat Q4 results.
    Check-Cap Ltd. (NASDAQ: CHEK) shares gained 9.8 percent to $4.92 as the company announced the publication of CE Mark multicenter clinical study results on C-Scan® in Gut.
    Arcimoto, Inc. (NASDAQ: FUV) rose 8.3 percent to $3.41.
    Ferroglobe PLC (NYSE: GSM) gained 7 percent to $12.13 following stronger-than-expected quarterly earnings.
    Photronics, Inc. (NASDAQ: PLAB) shares climbed 6.5 percent to $9.00 after the company reported upbeat Q2 results.
    Micron Technology, Inc. (NASDAQ: MU) rose 6.2 percent to $58.94 after reporting a $10 billion buyback plan.
    Blink Charging Co. (NASDAQ: BLNK) gained 6.2 percent to $7.53. Blink Charging disclosed that its vehicle charging network exceeds 125,000 members.
    The Container Store Group, Inc. (NYSE: TCS) gained 5.4 percent to $7.97. Container Store is expected to release quarterly earnings after the closing bell.
    Cyren Ltd (NASDAQ: CYRN) shares rose 5.4 percent to $2.95 after reporting Q1 results.

    Check out these big penny stock gainers and losers

  • [By Lisa Levin] Gainers
    Pacific Biosciences of California, Inc. (NASDAQ: PACB) rose 11.4 percent to $2.93 in pre-market trading.
    Check-Cap Ltd. (NASDAQ: CHEK) shares rose 6.3 percent to $4.76 in pre-market trading as the company announced the publication of CE Mark multicenter clinical study results on C-Scan® in Gut.
    Acacia Communications, Inc. (NASDAQ: ACIA) rose 6 percent to $ 35.20 in pre-market trading.
    Cellect Biotechnology Ltd. (NASDAQ: APOP) rose 6 percent to $7.60 in pre-market trading.
    Hexindai Inc. (NASDAQ: HX) rose 5.7 percent to $12.70 in pre-market trading.
    MoSys, Inc. (NASDAQ: MOSY) shares rose 5.3 percent to $2.07 in pre-market trading.
    Micron Technology, Inc. (NASDAQ: MU) rose 5 percent to $58.20 in pre-market trading after reporting a $10 billion buyback plan.
    Golden Ocean Group Limited (NASDAQ: GOGL) rose 4.1 percent to $8.63 in pre-market trading.
    MorphoSys AG (NASDAQ: MOR) rose 3.5 percent to $26.99 in pre-market trading.
    Cyren Ltd (NASDAQ: CYRN) shares rose 3.4 percent to $2.90 in pre-market trading. after reporting Q1 results.
    Box, Inc. (NYSE: BOX) rose 3.4 percent to $28.76 in pre-market trading.
    Kohl's Corporation (NYSE: KSS) shares rose 3.3 percent to $67.60 in the pre-market trading session after the company reported upbeat quarterly earnings.
    Micro Focus International plc (NYSE: MFGP) shares rose 3.1 percent to $18.40 in pre-market trading.

     

Top 5 Value Stocks To Watch For 2018: CareDx, Inc.(CDNA)

Advisors’ Opinion:

  • [By Money Morning Staff Reports]

    After looking at this week’s penny stock gainers, we’ll give you that leg up with one of our top-rated penny stocks from our proprietary stock ranking system…

    Penny Stock Current Share Price (March 26) Last Week’s Gain
    Cartesian Inc. (OTCMKTS: CRTN) $0.39 170.69%
    Odyssey Marine Exploration Inc. (Nasdaq: OMEX) $8.76 135.90%
    iFresh Inc. (Nasdaq: IFMK) $8.25 64.64%
    China Auto Logistics Inc. (Nasdaq: CALI) $4.68 47.43%
    National American University Holdings Inc. (Nasdaq: NAUH) $1.20 39.29%
    Document Security Systems Inc. (NYSE: DSS) $1.58 33.91%
    Blonder Tongue Labs Inc. (NYSE: BDR) $0.77 33.90%
    CareDx Inc. (Nasdaq: CDNA) $7.49 29.88%
    Mediwound Ltd. (Nasdaq: MDWD) $5.10 26.51%
    New York & Co. Inc. (NYSE: NWY) $3.37 26.35%

    Don’t Miss This Shot at a $78,000 Windfall: This tiny firm is about to make the entire world wire-free. As its game-changing technology revolutionizes the global power structure, its stock could hand investors a massive return. Learn more…

  • [By Shane Hupp]

    Genomic Health (NASDAQ: GHDX) and CareDx (NASDAQ:CDNA) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, analyst recommendations, risk, profitability, institutional ownership, valuation and earnings.

Top 5 Value Stocks To Watch For 2018: Enzymotec Ltd.(ENZY )

Advisors’ Opinion:

  • [By Logan Wallace]

    Press coverage about Enzymotec (NASDAQ:ENZY) has trended positive this week, Accern Sentiment reports. The research firm identifies positive and negative news coverage by reviewing more than twenty million news and blog sources. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. Enzymotec earned a coverage optimism score of 0.36 on Accern’s scale. Accern also assigned media headlines about the biotechnology company an impact score of 44.1639541610912 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the near term.

Top 5 Value Stocks To Watch For 2018: Natera, Inc.(NTRA)

Advisors’ Opinion:

  • [By Logan Wallace]

    Natera (NASDAQ:NTRA) had its price target upped by Morgan Stanley from $15.00 to $16.00 in a research note issued to investors on Wednesday. Morgan Stanley currently has an overweight rating on the medical research company’s stock.

  • [By Logan Wallace]

    Natera (NASDAQ:NTRA) was downgraded by investment analysts at ValuEngine from a “buy” rating to a “hold” rating in a report issued on Monday.

Top Growth Stocks To Watch Right Now

Cellular Biomedicine Group (NASDAQ:CBMG) has investment potential for a number of reasons. Its primary market, China, has at least four times the population of the United States, and has an aging population, and CBMG is interested in the US market too. Its last 10-K states that ‘stem cell products for injection into painful joints’ will fuel an overall increase in the use of US stem cell-based treatments, with an increase to $5.7 billion in 2020. A sizeable market.

Key growth areas for stem cell treatments are spinal fusion, sports medicine, and osteoarthritis of the joints. Source CBMG 2016 10-K:

According to International Journal of Rheumatic Diseases, 2011, 53% of KOA patients will degenerate to the point of disability. Conventional treatment usually involves invasive surgery with painful recovery and physical therapy. As drug-based methods of management are ineffective, the same journal estimates that some 1.5 million patients with this disability will degenerate to the point of requiring artificial joint replacement surgery every year. However, only 40,000 patients will actually be able to undergo replacement surgery, leaving the majority of patients to suffer from a life-long disability due to lack of effective treatment.

Top Growth Stocks To Watch Right Now: Chatham Lodging Trust (REIT)(CLDT)

Advisors’ Opinion:

  • [By Shane Hupp]

    Teachers Insurance & Annuity Association of America raised its holdings in shares of Chatham Lodging (NYSE:CLDT) by 19.5% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 59,609 shares of the real estate investment trust’s stock after purchasing an additional 9,743 shares during the quarter. Teachers Insurance & Annuity Association of America owned 0.13% of Chatham Lodging worth $1,142,000 at the end of the most recent reporting period.

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Chatham Lodging (CLDT)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top Growth Stocks To Watch Right Now: Dell Technologies Inc. (DVMT)

Advisors’ Opinion:

  • [By Money Morning Staff Reports]

    The 1,610 cryptocurrencies on CoinMarketCap.com have a total market cap of $404 billion, making them worth more than Twitter Inc. (NYSE: TWTR), Snap Inc. (NYSE: SNAP), International Business Machines Corp. (NYSE: IBM), and Dell Technologies Inc. (NYSE: DVMT) combined.

  • [By Joseph Griffin]

    Here are some of the news headlines that may have impacted Accern Sentiment Analysis’s analysis:

    Get Dell Technologies alerts:

    Dell launches Customer Solution Center in UAE (khaleejtimes.com) Hilal Computers selected for Dell EMC President’s Circle (arabnews.com) Dell Technologies Customer Solution Centre opens in Dubai (tahawultech.com) Dell Technologies launches new Customer Solution Centre in UAE (itp.net) Dell Technologies (DVMT) Downgraded by Zacks Investment Research to Hold (americanbankingnews.com)

    NYSE DVMT traded up $0.30 during mid-day trading on Wednesday, hitting $74.22. The stock had a trading volume of 830,865 shares, compared to its average volume of 2,081,792. Dell Technologies has a 52-week low of $73.19 and a 52-week high of $74.78. The company has a market capitalization of $56.67 billion, a P/E ratio of 12.03, a PEG ratio of 1.41 and a beta of -0.45. The company has a debt-to-equity ratio of 2.94, a current ratio of 0.85 and a quick ratio of 0.79.

  • [By Stephan Byrd]

    Meeder Asset Management Inc. decreased its position in Dell Technologies (NYSE:DVMT) by 89.4% during the 1st quarter, according to its most recent disclosure with the SEC. The fund owned 1,948 shares of the company’s stock after selling 16,346 shares during the period. Meeder Asset Management Inc.’s holdings in Dell Technologies were worth $143,000 at the end of the most recent reporting period.

  • [By Dan Caplinger]

    Friday was a relatively quiet day on Wall Street, with a split among the most widely followed market benchmarks that sent some up and others down. Slight downticks in oil prices and bond yields marked minor reversals from upward trends earlier in the week, but investors are still watching both energy and bonds closely to see what long-term impact they might have on the stock market. Most attention centered on individual companies, some of which reported good news that sent their shares higher. Dell Technologies (NYSE:DVMT), Nektar Therapeutics (NASDAQ:NKTR), and Westport Fuel Systems (NASDAQ:WPRT) were among the best performers on the day. Here’s why they did so well.

Top Growth Stocks To Watch Right Now: Natera, Inc.(NTRA)

Advisors’ Opinion:

  • [By Logan Wallace]

    Natera (NASDAQ:NTRA) was downgraded by investment analysts at ValuEngine from a “buy” rating to a “hold” rating in a report issued on Monday.

  • [By Logan Wallace]

    Natera (NASDAQ:NTRA) had its price target upped by Morgan Stanley from $15.00 to $16.00 in a research note issued to investors on Wednesday. Morgan Stanley currently has an overweight rating on the medical research company’s stock.

Top 10 Safest Stocks To Own For 2018

Shutterstock

There’s no way around it: the S&P 500 now has a P/E ratio of more than 26 going into the first earnings season of 2017, and even the “safest” bets are starting to look scary.

Unless we see massive profit growth all around, there’s a real risk this bull market is going to stutter—or worse.

So where do you go for value? It’s getting harder than ever, but there is one corner of the market that got way ahead of the S&P 500 and has since taken a step back. I’m talking about real estate investment trusts (REITs).

And now, there are three REITs that combined provide over 9% in income with over 200% average dividend coverage. That means they could double their payouts and still generate enough cash to cover them.

Plus, these stocks are out of favor, making them relatively cheap compared to their peers and the overheated broader market.

Top 10 Safest Stocks To Own For 2018: Fisher(j)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Joincoin (CURRENCY:J) traded 1.7% lower against the U.S. dollar during the 24 hour period ending at 0:00 AM ET on May 8th. Joincoin has a total market cap of $145,714.00 and $7.00 worth of Joincoin was traded on exchanges in the last 24 hours. During the last week, Joincoin has traded up 28.6% against the U.S. dollar. One Joincoin coin can currently be bought for about $0.0471 or 0.00000521 BTC on cryptocurrency exchanges.

Top 10 Safest Stocks To Own For 2018: Nuveen Tax-Advantaged Total Return Strategy Fund(JTA)

Advisors’ Opinion:

  • [By Max Byerly]

    Wells Fargo & Company MN decreased its holdings in Nuveen Tax Advantaged Total Re (NYSE:JTA) by 48.2% in the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 10,813 shares of the investment management company’s stock after selling 10,055 shares during the period. Wells Fargo & Company MN owned approximately 0.08% of Nuveen Tax Advantaged Total Re worth $150,000 as of its most recent SEC filing.

Top 10 Safest Stocks To Own For 2018: Novo Nordisk A/S(NVO)

Advisors’ Opinion:

  • [By Logan Wallace]

    Eagle Global Advisors LLC decreased its position in Novo Nordisk (NYSE:NVO) by 10.7% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 130,420 shares of the company’s stock after selling 15,550 shares during the period. Eagle Global Advisors LLC’s holdings in Novo Nordisk were worth $6,423,000 as of its most recent SEC filing.

  • [By Brian Orelli]

    Novo Nordisk (NYSE:NVO) continues its trend ofrelatively strong growth of its newer diabetes medications being offset by slower growth of older insulin drugs in the first quarter. Currency changes also negatively affected Novo’s revenue line, but that’s out of the company’s control.

  • [By Stephan Byrd]

    Atria Investments LLC trimmed its stake in Novo Nordisk (NYSE:NVO) by 17.4% during the first quarter, according to its most recent disclosure with the SEC. The fund owned 7,081 shares of the company’s stock after selling 1,495 shares during the quarter. Atria Investments LLC’s holdings in Novo Nordisk were worth $349,000 as of its most recent SEC filing.

Top 10 Safest Stocks To Own For 2018: Just Hold Your Nose and Dive Into Under Armour Inc (UAA)

Advisors’ Opinion:

  • [By Anders Bylund, Tyler Crowe, and Demitrios Kalogeropoulos]

    Demitri Kalogeropoulos (Nike):Rival Under Armour (NYSE:UA) (NYSE:UAA) lost over 50% of its value in 2017, but you don’t have to worry about seeing Nike go through a similarly painful experience anytime soon. In fact, the athletic apparel and footwear giant’s business is healthy enough that shareholders can feel comfortable that this investment will hold up over the long term.

  • [By Leo Sun]

    Under Armour (NYSE:UA) (NYSE:UAA) was once hailed as the “next Nike,” but 37% of its class A shares were being shorted as of April 10. Both classes of the stock have stumbled more than 60% over the past two years.

  • [By Jeremy Bowman]

    Unfortunately for Under Armour (NYSE:UAA)(NYSE:UA), this year’s survey results confirmed a lot of concerns investors have about the brand.

    Image source: Getty Images.

  • [By ]

    (1) William Blair keeping it real on Under Armour (UAA) ahead of May 1 earnings: “Although we see limited near-term downside to shares given our projection for an okay first quarter relative to expectations combined with a high short interest (13 days to cover), we remain cautious given a premium valuation (118 times for Class A and 102 times for Class C), little evidence of a fundamental catalyst to drive top-line growth, and concerns about brand commoditization stemming from new domestic retail channels and a lack of consumer-relevant innovation.”

Top 10 Safest Stocks To Own For 2018: BlackBerry Limited(BBRY)

Advisors’ Opinion:

  • [By Shane Hupp]

    BlackBerry (TSE:BB) (NASDAQ:BBRY)‘s stock had its “in-line” rating reiterated by analysts at Imperial Capital in a report issued on Wednesday.

Top 10 Safest Stocks To Own For 2018: Natera, Inc.(NTRA)

Advisors’ Opinion:

  • [By Logan Wallace]

    Natera (NASDAQ:NTRA) had its price target upped by Morgan Stanley from $15.00 to $16.00 in a research note issued to investors on Wednesday. Morgan Stanley currently has an overweight rating on the medical research company’s stock.

  • [By Logan Wallace]

    Natera (NASDAQ:NTRA) was downgraded by investment analysts at ValuEngine from a “buy” rating to a “hold” rating in a report issued on Monday.

Top 10 Safest Stocks To Own For 2018: BP Prudhoe Bay Royalty Trust(BPT)

Advisors’ Opinion:

  • [By Joseph Griffin]

    News headlines about BP Prudhoe Bay Royalty Trust (NYSE:BPT) have been trending somewhat positive this week, Accern Sentiment reports. Accern identifies negative and positive news coverage by monitoring more than 20 million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. BP Prudhoe Bay Royalty Trust earned a daily sentiment score of 0.09 on Accern’s scale. Accern also gave media headlines about the oil and gas company an impact score of 46.2072909143413 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the next several days.

Top 10 Safest Stocks To Own For 2018: Taseko Mines Limited(TGB)

Advisors’ Opinion:

  • [By Logan Wallace]

    Taseko Mines (NYSEAMERICAN:TGB) (TSE:TKO) has earned a consensus rating of “Buy” from the seven research firms that are currently covering the company, Marketbeat.com reports. Two research analysts have rated the stock with a hold rating and four have given a buy rating to the company.

Top 10 Safest Stocks To Own For 2018: Walker & Dunlop, Inc.(WD)

Advisors’ Opinion:

  • [By Keith Speights]

    Gilead Sciences (NASDAQ:GILD), Micron Technology (NASDAQ:MU), and Walker & Dunlop (NYSE:WD) actually have relatively low valuations. Here’s why these are three bargain stocks you can buy right now.

Top 10 Safest Stocks To Own For 2018: Berkshire Hathaway Inc. (BRK-B)

Advisors’ Opinion:

  • [By Matthew Frankel]

    Warren Buffett and the rest of Berkshire Hathaway’s (NYSE:BRK-A) (NYSE:BRK-B) management have had a lingering problem for some time: Cash continues to build up on the balance sheet and there hasn’t been any attractive way to put it to work. At the end of 2017, Berkshire had more than $116 billion in cash and equivalents — far more than the $20 billion or so Buffett likes to keep on hand.

  • [By Jordan Wathen]

    Warren Buffett has often said in interviews and annual letters to shareholders that Berkshire Hathaway (NYSE:BRK-A)(NYSE:BRK-B) won’t be a hostile acquirer. That is, it won’t fight to buy a business its owners or management don’t want to sell. But that policy apparently doesn’t apply when Berkshire is acting as seller rather than a buyer.

  • [By Dan Caplinger]

    Warren Buffett is one of the most successful investors of all time, and one of the reasons why his high-performing Berkshire Hathaway (NYSE:BRK-A) (NYSE:BRK-B) has done as well as it has is because of Buffett’s mind-set. Berkshire’s CEO seeks out businesses that already embrace the principles that he values, and corporate leaders at many of the companies that he has acquired over the years choose to become part of Berkshire Hathaway because they know that the Oracle of Omaha’s interests will be aligned with their own.

Natera (NTRA) Price Target Raised to $16.00

Natera (NASDAQ:NTRA) had its price target upped by Morgan Stanley from $15.00 to $16.00 in a research note issued to investors on Wednesday. Morgan Stanley currently has an overweight rating on the medical research company’s stock.

A number of other analysts have also recently issued reports on the stock. BidaskClub cut shares of Natera from a sell rating to a strong sell rating in a research note on Wednesday, February 28th. Zacks Investment Research cut shares of Natera from a hold rating to a sell rating in a research note on Tuesday, January 23rd. Craig Hallum started coverage on shares of Natera in a research note on Monday, April 9th. They set a buy rating and a $16.00 target price for the company. Finally, ValuEngine upgraded shares of Natera from a sell rating to a hold rating in a research note on Wednesday, April 11th. One research analyst has rated the stock with a sell rating, one has given a hold rating and six have assigned a buy rating to the company. Natera currently has a consensus rating of Buy and a consensus target price of $14.80.

Get Natera alerts:

Natera opened at $11.72 on Wednesday, according to MarketBeat Ratings. The company has a quick ratio of 1.29, a current ratio of 1.37 and a debt-to-equity ratio of -7.05. The stock has a market cap of $650.20 million, a PE ratio of -4.88 and a beta of 2.07. Natera has a 52-week low of $7.78 and a 52-week high of $14.76.

Natera (NASDAQ:NTRA) last posted its earnings results on Tuesday, May 8th. The medical research company reported ($0.61) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.60) by ($0.01). The company had revenue of $62.34 million for the quarter, compared to analyst estimates of $54.86 million. Natera had a negative return on equity of 533.79% and a negative net margin of 58.84%. The business’s quarterly revenue was up 26.2% compared to the same quarter last year. During the same quarter in the prior year, the business posted ($0.70) EPS. equities research analysts expect that Natera will post -1.85 earnings per share for the current year.

A number of institutional investors have recently modified their holdings of NTRA. Trexquant Investment LP acquired a new stake in Natera in the 1st quarter worth about $119,000. MetLife Investment Advisors LLC acquired a new stake in Natera in the 4th quarter worth about $124,000. Jefferies Group LLC acquired a new stake in Natera in the 4th quarter worth about $130,000. Wells Fargo & Company MN raised its stake in Natera by 69.2% in the 3rd quarter. Wells Fargo & Company MN now owns 30,504 shares of the medical research company’s stock worth $393,000 after purchasing an additional 12,473 shares in the last quarter. Finally, Swiss National Bank raised its stake in Natera by 13.2% in the 1st quarter. Swiss National Bank now owns 47,900 shares of the medical research company’s stock worth $444,000 after purchasing an additional 5,600 shares in the last quarter. Institutional investors and hedge funds own 68.45% of the company’s stock.

About Natera

Natera, Inc, a diagnostics company, provides preconception and prenatal genetic testing services. It primarily offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus typically with a blood draw from the mother; Vistara, a single-gene mutations screening test to identify single-gene disorder; Horizon carrier screening to determine carrier status for various genetic diseases that could be passed on to the carrier's children; and Spectrum pre-implantation genetic screening and Spectrum pre-implantation genetic diagnosis to analyze chromosomal anomalies or inherited genetic conditions during an in vitro fertilization cycle.

Analyst Recommendations for Natera (NASDAQ:NTRA)

Hot Value Stocks To Watch Right Now

Leawood, KS, based Investment company Financial Advisory Service, Inc. buys iShares Core MSCI EAFE, Vanguard Small-Cap Value, iShares S&P SmallCap 600 Value, Vanguard Total World Stock Index, The Kroger Co, iShares Edge MSCI Min Vol Global, sells Amgen Inc, SPDR S&P Dividend, Verizon Communications Inc, iShares Morningstar Large-Cap Growth, MPLX LP during the 3-months ended 2017-12-31, according to the most recent filings of the investment company, Financial Advisory Service, Inc.. As of 2017-12-31, Financial Advisory Service, Inc. owns 157 stocks with a total value of $280 million. These are the details of the buys and sells.

New Purchases: IEFA, VT, KR, ACWV, Added Positions: VBR, IJS, SCHZ, SCHF, EFV, VCSH, MUB, SHM, IVW, SCHV, Reduced Positions: GVI, AMGN, SDY, VZ, AGG, CERN, EXAS, BND, INTC, MCD, Sold Out: JKE, MPLX, SLB, KMI, AMLP,

For the details of Financial Advisory Service, Inc.’s stock buys and sells, go to http://www.gurufocus.com/StockBuy.php?GuruName=Financial+Advisory+Service%2C+Inc.

Hot Value Stocks To Watch Right Now: Natera, Inc.(NTRA)

Advisors’ Opinion:

  • [By Logan Wallace]

    Natera (NASDAQ:NTRA) had its price target upped by Morgan Stanley from $15.00 to $16.00 in a research note issued to investors on Wednesday. Morgan Stanley currently has an overweight rating on the medical research company’s stock.

Hot Value Stocks To Watch Right Now: Health Insurance Innovations, Inc.(HIIQ)

Advisors’ Opinion:

  • [By Logan Wallace]

    Health Insurance Innovations (NASDAQ:HIIQ) was upgraded by investment analysts at ValuEngine from a “hold” rating to a “buy” rating in a note issued to investors on Wednesday.

  • [By Stephan Byrd]

    Health Insurance Innovations (NASDAQ: HIIQ) and Crawford & Company (NYSE:CRD.B) are both small-cap finance companies, but which is the superior investment? We will contrast the two businesses based on the strength of their valuation, dividends, risk, institutional ownership, analyst recommendations, earnings and profitability.

  • [By Shane Hupp]

    Health Insurance Innovations (NASDAQ:HIIQ) saw unusually-high trading volume on Thursday after the company announced better than expected quarterly earnings. Approximately 2,255,517 shares were traded during mid-day trading, an increase of 457% from the previous session’s volume of 404,884 shares.The stock last traded at $28.70 and had previously closed at $27.65.

Hot Value Stocks To Watch Right Now: Medical Marijuana, Inc. (MJNA)

Advisors’ Opinion:

  • [By ]

    Cronos was the first cannabis company to trade on NASDAQ, but the first American cannabis company to do it was Medical Marijuana Inc. (MJNA) . Developing legal cannabidiol (CBD) products made from hemp, Medical Marijuana Inc. had a major increase in sales from 2016 to 2017 and has begun looking into an expansion into international markets. Like with Aurora, these expenses have meant that it’s not making much of a profit. With encouraging signs and warning signs each abounding, it comes down to whether you think this could be worth the risk.

  • [By Sean Williams]

    If I were to choose two marijuana stocks right off the bat that I’d rather watch from the sidelines and never buy, it’d be medical cannabis company Medical Marijuana Inc. (NASDAQOTH:MJNA) and cannabinoid-based drug developer AXIM Biotechnologies (NASDAQOTH:AXIM). The reason they’re listed together is because Medical Marijuana Inc. owns 22.67 million shares of AXIM, which is about 40% of its outstanding share count. Their futures really are tied together.

Hot Value Stocks To Watch Right Now: A V Homes, Inc.(AVHI)

Advisors’ Opinion:

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    World Fuel Services Corporation (NYSE: INT) tumbled 18 percent to $22.90 following Q1 results.
    Biglari Holdings Inc. (NYSE: BH) fell 17.4 percent to $349.52. Washington Prime Group will replace Biglari Holdings in the S&P SmallCap 600 on Tuesday, May 1.
    Flex Ltd. (NASDAQ: FLEX) dipped 15.7 percent to $14.03 after a mixed fourth quarter report.
    FormFactor, Inc. (NASDAQ: FORM) fell 15.3 percent to $11.65. FormFactor is expected to release Q1 results on May 2.
    Data I/O Corporation (NASDAQ: DAIO) dropped 14.3 percent to $6.24 following Q1 results.
    National Instruments Corporation (NASDAQ: NATI) fell 14.3 percent to $ 42.34 after reporting Q1 results.
    United States Steel Corporation (NYSE: X) dipped 14.2 percent to $32.37 following Q1 results.
    Civeo Corporation (NYSE: CVEO) dropped 13.5 percent to $3.33. Civeo posted a Q1 loss of $0.42 per share on sales of $101.504 million.
    athenahealth, Inc. (NASDAQ: ATHN) fell 12.4 percent to $125.310 after reporting Q1 results.
    Charter Communications, Inc. (NASDAQ: CHTR) shares tumbled 12.1 percent to $262.06 as the company posted Q1 results.
    Value Line, Inc. (NASDAQ: VALU) fell 11.3 percent to $19.10.
    Federated Investors, Inc. (NYSE: FII) shares dropped 11.2 percent to $27.605 after the company posted downbeat quarterly earnings.
    AV Homes, Inc. (NASDAQ: AVHI) declined 10.7 percent to $17.20 following Q1 results.
    CalAmp Corp. (NASDAQ: CAMP) dropped 9.4 percent to $21.01 after reporting Q4 results.
    Tandem Diabetes Care, Inc. (NASDAQ: TNDM) shares fell 8.9 percent to $7.280 following mixed Q1 results.
    Sony Corporation (NYSE: SNE) shares fell 8.4 percent to $45.97 after reporting Q4 results.
    LogMeIn Inc (NASDAQ: LOGM) fell 8.2 percent to $109.825. LogMeIn reported upbeat earnings for its first quarter, but issued weak second quarter and FY18 earning guidance.
    Eleven Biotherapeutics, Inc. (NASDAQ: EBIO